Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 779.83mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 779.83mg eqv. metformin hydrochloride 1000.000mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 389.91mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 389.91mg eqv. metformin hydrochloride 500.000mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 662.85mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 662.85mg eqv. metformin hydrochloride 850.000mg

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - linagliptin; metformin hydrochloride - tablet - 2.5mg; 500mg - linagliptin 2.5mg; metformin hydrochloride 500mg - biguanides

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - linagliptin; metformin hydrochloride - tablet - 2.5mg; 850mg - linagliptin 2.5mg; metformin hydrochloride 850mg - biguanides

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - linagliptin; metformin hydrochloride - tablet - 2.5mg; 1000mg - linagliptin 2.5mg; metformin hydrochloride 1000mg - biguanides

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - linagliptin; metformin hydrochloride - tablet - 2.5mg ; 850mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - metformin hydrochloride; linagliptin - tablet - 1000mg ; 2.5mg

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - linagliptin, metformin - diabetes mellitus, type 2 - drugs used in diabetes, - treatment of adult patients with type-2 diabetes mellitus:jentadueto is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of linagliptin and metformin.jentadueto is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - linagliptin, metformin - diabetes mellitus, type 2 - drugs used in diabetes, - treatment of adult patients with type-2 diabetes mellitus:jentadueto is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of linagliptin and metformin.jentadueto is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.